Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Current Drug Targets|July 10, 2013
Nuclear export mediated regulation of microRNAs: potential target for drug interventionIrfana Muqbil, Bin Bao, Abdul Badi Abou-Samra, et al.Cancers|August 7, 2019
DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Yiwei Li, Amro Aboukameel, et al.Medical Oncology (Northwood, London, England)|September 29, 2020
Restraint stress abates the antioxidant potential of melatonin on dimethyl benz (a) anthracene (DMBA) induced carcinogenesisIrfana Muqbil, Sabiha Fatima, Asfar S Azmi, et al.Cancer Metastasis Reviews|January 9, 2024
Deciphering cellular plasticity in pancreatic cancer for effective treatmentsMd Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, et al.Journal of Stem Cell Research & Therapy|December 10, 2013
Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and TherapyIrfana Muqbil, Ginny W Bao, Rkya El-Kharraj, et al.Current Pharmaceutical Design|February 1, 2012
Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrolIrfana Muqbil, Frances W J Beck, Bin Bao, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 15, 2012
Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injuryRamazan Ulu, Ayhan Dogukan, Mehmet Tuzcu, et al.Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.Biological Trace Element Research|January 14, 2014
Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicityKazim Sahin, Cemal Orhan, Mehmet Tuzcu, et al.Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.Pageof 4